StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$58.65+0.77 (+1.33%)

Close on Nov 18, 2026Market cap $3.00BP/E 139.6Yield –

Vericel shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Vericel's shares outstanding was 52M at Jun 30, 2026. For fiscal 2025 it was 52M, up 0.9% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is 52M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202552M+0.9%
FY2024Dec 31, 202452M+8.6%
FY2023Dec 31, 202348M+1.0%
FY2022Dec 31, 202247M+1.4%
FY2021Dec 31, 202146M-1.7%
FY2020Dec 31, 202047M+7.0%
FY2019Dec 31, 201944M+9.8%
FY2018Dec 31, 201840M+20.6%
FY2017Dec 31, 201733M+44.4%
FY2016Dec 31, 201623M-2.8%
FY2015Dec 31, 201524M+104.1%
FY2014Dec 31, 201412M+286.0%
FY2013Dec 31, 20133M+46.4%
FY2012Dec 31, 20122M+66.6%
FY2010Jun 30, 20101M+38.3%
FY2009Jun 30, 20091M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202652M+3.9%
Q1 FY2026Mar 31, 202651M+1.7%
Q4 FY2025Dec 31, 202558M-4.9%
Q3 FY2025Sep 30, 202552M+5.8%
Q2 FY2025Jun 30, 202550M+3.5%
Q1 FY2025Mar 31, 202550M+3.7%
Q4 FY2024Dec 31, 202461M+27.3%
Q3 FY2024Sep 30, 202449M+3.0%
Q2 FY2024Jun 30, 202449M+2.3%
Q1 FY2024Mar 31, 202448M+1.6%
Q4 FY2023Dec 31, 202348M+1.1%
Q3 FY2023Sep 30, 202348M+1.0%
Q2 FY2023Jun 30, 202348M+1.0%
Q1 FY2023Mar 31, 202347M+0.9%
Q4 FY2022Dec 31, 202247M+0.9%
Q3 FY2022Sep 30, 202247M+1.1%
Q2 FY2022Jun 30, 202247M+1.5%
Q1 FY2022Mar 31, 202247M+2.2%
Q4 FY2021Dec 31, 202147M-13.0%
Q3 FY2021Sep 30, 202147M-1.4%
Q2 FY2021Jun 30, 202146M+2.8%
Q1 FY2021Mar 31, 202146M+2.4%
Q4 FY2020Dec 31, 202054M+20.1%
Q3 FY2020Sep 30, 202047M+1.4%
Q2 FY2020Jun 30, 202045M+2.7%
Q1 FY2020Mar 31, 202045M+2.7%
Q4 FY2019Dec 31, 201945M+3.0%
Q3 FY2019Sep 30, 201947M+8.7%
Q2 FY2019Jun 30, 201944M+14.6%
Q1 FY2019Mar 31, 201944M+21.0%
Q4 FY2018Dec 31, 201843M+24.0%
Q3 FY2018Sep 30, 201843M+27.5%
Q2 FY2018Jun 30, 201838M+17.0%
Q1 FY2018Mar 31, 201836M+13.3%
Q4 FY2017Dec 31, 201735M+44.1%
Q3 FY2017Sep 30, 201734M+48.0%
Q2 FY2017Jun 30, 201733M–
Q1 FY2017Mar 31, 201732M–
Q4 FY2016Dec 31, 201624M–
Q3 FY2016Sep 30, 201623M–

More Vericel figures

See a number that looks wrong?